Drug Shortage Report for PRO-LORAZEPAM
Report ID | 67702 |
Drug Identification Number | 00655651 |
Brand name | PRO-LORAZEPAM TAB 1.0MG |
Common or Proper name | LORAZEPAM |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1000 |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-11-27 |
Estimated end date | |
Actual end date | 2018-11-29 |
Shortage status | Resolved |
Updated date | 2018-11-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-11-30 | English | Compare |
v5 | 2018-11-29 | French | Compare |
v4 | 2018-11-29 | English | Compare |
v3 | 2018-11-28 | English | Compare |
v2 | 2018-11-27 | French | Compare |
v1 | 2018-11-27 | English | Compare |
Showing 1 to 6 of 6